Trial Information
Current as of January 14, 2025
Completed
Keywords
ClinConnect Summary
Nowadays Interleukin 17 has a major role in the pathogenesis of psoriasis Vulgaris.
the aim of this study to evaluate the serum levels of Interleukin 17 in psoriatic patients and compare them with the levels in healthy controls \& evaluate the effect of narrow-band ultraviolet B (NB-UVB) on the serum of Interleukin 17 and the treatment of psoriasis Vulgaris. This prospective randomized clinical trial was carried out in Dermatology Department, South Valley University Hospitals included from September 2020 to August 2021, enrolled 40 psoriatic patients and 40 controls. The study was submitte...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with psoriasis diagnosed clinically
- Exclusion Criteria:
- • Patient with history of skin cancer. Patient with history of photosensitivity. Patient receiving immune suppressive drugs .
Trial Officials
Hassan M Ibrahim, professor
Study Director
South Valley University
About South Valley University
South Valley University is a reputable academic institution dedicated to advancing healthcare through innovative research and clinical trials. Committed to fostering excellence in medical education and patient care, the university collaborates with leading healthcare professionals and researchers to conduct rigorous clinical studies aimed at improving treatment outcomes and patient safety. With a strong emphasis on ethical standards and scientific integrity, South Valley University is poised to contribute valuable insights to the medical community and enhance the overall understanding of various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Qinā, Qena, Egypt
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials